{"transactions":[{"id":856006,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62303,"kind":"person","name":"Gendreau Roger Michael","position":1,"cik":"0001826131","reported_name":"Gendreau Roger Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-06T21:17:32.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on March 5, 2027 and 1/24th monthly thereafter."}],"balance_after":82500,"derivative":{"exercise_price":2.86,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001826131-26-000002","document":"form4-03062026_090328.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000182613126000002/form4-03062026_090328.xml","form_type":"4"}},{"id":979152,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62303,"kind":"person","name":"Gendreau Roger Michael","position":1,"cik":"0001826131","reported_name":"Gendreau Roger Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T21:05:07.000Z","date":"2025-12-04","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on December 4, 2026 and 1/24th monthly thereafter."}],"balance_after":150000,"derivative":{"exercise_price":6.14,"expiration_date":"2035-12-04","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001826131-25-000005","document":"form4-12052025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000182613125000005/form4-12052025_041201.xml","form_type":"4"}},{"id":1097988,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62303,"kind":"person","name":"Gendreau Roger Michael","position":1,"cik":"0001826131","reported_name":"Gendreau Roger Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-01T18:11:12.000Z","date":"2025-06-27","kind":"grant","planned":false,"acquired":true,"shares":12075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter."}],"balance_after":12075,"derivative":{"exercise_price":4.71,"expiration_date":"2035-06-27","underlying":"Common Stock","underlying_shares":12075},"source":{"system":"sec-edgar","filing":"0001415889-25-018653","document":"form4-07012025_060708.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588925018653/form4-07012025_060708.xml","form_type":"4"}},{"id":1612516,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62303,"kind":"person","name":"Gendreau Roger Michael","position":1,"cik":"0001826131","reported_name":"Gendreau Roger Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-28T17:43:15.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":88085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest 100% on February 26, 2025, one year following the grant date."}],"balance_after":88085,"derivative":{"exercise_price":0.357,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":88085},"source":{"system":"sec-edgar","filing":"0001415889-24-005668","document":"form4-02282024_050208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588924005668/form4-02282024_050208.xml","form_type":"4"}},{"id":2086617,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62303,"kind":"person","name":"Gendreau Roger Michael","position":1,"cik":"0001826131","reported_name":"Gendreau Roger Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-14T23:30:25.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter."}],"balance_after":80000,"derivative":{"exercise_price":0.2789,"expiration_date":"2032-12-12","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-22-012558","document":"form4-12142022_111202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922012558/form4-12142022_111202.xml","form_type":"4"}},{"id":2218774,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62303,"kind":"person","name":"Gendreau Roger Michael","position":1,"cik":"0001826131","reported_name":"Gendreau Roger Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T17:53:44.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests one-third on June 23, 2023 and 1/24th monthly thereafter."}],"balance_after":40000,"derivative":{"exercise_price":4.23,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-22-007083","document":"form4-06302022_100635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000141588922007083/form4-06302022_100635.xml","form_type":"4"}},{"id":2909759,"issuer":{"id":6845,"kind":"organization","name":"Dogwood Therapeutics, Inc."},"owners":[{"id":62303,"kind":"person","name":"Gendreau Roger Michael","position":1,"cik":"0001826131","reported_name":"Gendreau Roger Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-13T00:43:39.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":41734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock option granted pursuant to the reporting person's employment agreement. The stock option vests one-third on January 1, 2022 and 1/24th monthly thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted pursuant to the reporting person's employment agreement. The stock option vests one-third on January 1, 2022 and 1/24th monthly thereafter."}],"balance_after":41734,"derivative":{"exercise_price":7.51,"expiration_date":"2031-01-01","underlying":"Common Stock","underlying_shares":41734},"source":{"system":"sec-edgar","filing":"0001104659-21-003572","document":"tm212264d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465921003572/tm212264d2_4.xml","form_type":"4"}}]}